Rhinovirus-associated pulmonary exacerbations show a lack of FEV1 improvement in children with cystic fibrosis.
Fiche publication
Date publication
mars 2016
Journal
Influenza and other respiratory viruses
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ABELY Michel
Tous les auteurs :
Cousin M, Molinari N, Foulongne V, Caimmi D, Vachier I, Abely M, Chiron R
Lien Pubmed
Résumé
Respiratory viral infections lead to bronchial inflammation in patients with cystic fibrosis, especially during pulmonary exacerbations. The aim of this study was to determine the impact of viral-associated pulmonary exacerbations in children with cystic fibrosis and failure to improve forced expiratory volume in 1 s (FEV1 ) after an appropriate treatment.
Mots clés
Adolescent, Anti-Bacterial Agents, therapeutic use, Child, Cystic Fibrosis, complications, Disease Management, Disease Progression, Female, Forced Expiratory Volume, drug effects, Humans, Lung, physiopathology, Male, Picornaviridae Infections, complications, Pilot Projects, Respiratory Function Tests, Respiratory Tract Infections, complications, Rhinovirus, drug effects, Risk Factors
Référence
Influenza Other Respir Viruses. 2016 Mar;10(2):109-12